PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
300401 Zhejiang Garden Biopharmaceutical
- 15.25
- -0.70-4.39%
Market Closed Apr 25 15:00 CST
8.29BMarket Cap26.38P/E (TTM)
16.10High15.15Low523.05KlotVolume16.00Open15.95Pre Close804.92MTurnover9.78%Turnover Ratio26.80P/E (Static)543.47MShares18.4652wk High2.69P/B8.15BFloat Cap10.7252wk Low19.14Limit Up534.68MShs Float24.96Historical High12.76Limit Down5.96%Amplitude1.12Historical Low0.11Dividend TTM15.39Avg Price262.53KlotAsk0.75%Div YieldTTM100Lot Size240.58KlotBid
Zhejiang Garden Biopharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.18%326.39M | 13.58%1.24B | 4.43%937.59M | -8.61%600.17M | 4.15%330.27M | -22.78%1.09B | -16.74%897.78M | -17.96%656.74M | -17.97%317.12M | 26.89%1.42B |
| Operating revenue | -1.18%326.39M | 13.58%1.24B | 4.43%937.59M | -8.61%600.17M | 4.15%330.27M | -22.78%1.09B | -16.74%897.78M | -17.96%656.74M | -17.97%317.12M | 26.89%1.42B |
| Other operating revenue | ---- | 73.66%22.45M | ---- | 67.58%10.23M | ---- | -36.59%12.93M | ---- | -59.45%6.11M | ---- | 109.02%20.39M |
| Total operating cost | -13.63%225.27M | 1.32%952.33M | -4.76%715.84M | -11.14%478.58M | -3.36%260.82M | -7.53%939.88M | 5.10%751.58M | 8.01%538.59M | 15.30%269.88M | 52.14%1.02B |
| Operating cost | 2.51%140.99M | 17.63%516.75M | 8.82%392.2M | 2.80%256.04M | 12.56%137.54M | -8.71%439.31M | 4.55%360.39M | 1.68%249.06M | 14.68%122.19M | 39.27%481.25M |
| Operating tax surcharges | 83.25%4.54M | 21.41%23.07M | 40.98%14.17M | 26.86%10.74M | 59.57%2.48M | 16.58%19M | -6.26%10.05M | 14.29%8.47M | -54.97%1.55M | 11.00%16.3M |
| Operating expense | -42.86%36.9M | -23.29%193.58M | -27.03%155.33M | -32.81%107.47M | -24.34%64.58M | -25.11%252.36M | -15.49%212.88M | -5.86%159.96M | 4.18%85.36M | 83.77%336.98M |
| Administration expense | -18.99%22.79M | -8.93%115.8M | -24.02%75.54M | -28.12%53.18M | -23.73%28.13M | 13.01%127.14M | 42.53%99.42M | 64.39%73.99M | 74.35%36.89M | 41.92%112.5M |
| Financial expense | -51.23%3.67M | 73.66%19.36M | 112.02%18.91M | 115.77%10.09M | 2.03%7.53M | 1,290.76%11.15M | 258.54%8.92M | 262.16%4.68M | 69.73%7.38M | 93.35%-936.09K |
| -Interest expense (Financial expense) | -22.65%7.91M | -7.24%35.63M | -12.92%28.14M | -17.08%19.33M | 9.77%10.23M | 76.06%38.41M | 94.84%32.32M | 114.93%23.31M | 82.24%9.32M | 101.91%21.82M |
| -Interest Income (Financial expense) | -60.10%-1.87M | 49.91%-10.29M | 50.41%-8.11M | 49.33%-5.93M | 71.97%-1.17M | -67.01%-20.54M | -94.88%-16.35M | -123.57%-11.7M | -219.40%-4.16M | 55.84%-12.3M |
| Research and development | -20.34%16.38M | -7.85%83.78M | -0.39%59.69M | -3.28%41.05M | 24.48%20.56M | 29.24%90.91M | 37.26%59.93M | 41.18%42.44M | -0.74%16.51M | 18.66%70.34M |
| Credit Impairment Loss | 17.60%-983.52K | -182.76%-1.97M | -776.26%-3.04M | -74.74%-873.89K | -285.11%-1.19M | 194.28%2.39M | 159.94%449.96K | 63.78%-500.1K | 549.10%644.8K | -689.17%-2.53M |
| Asset Impairment Loss | ---- | -85.30%-2.51M | 151.22%491.1K | 178.96%491.1K | 100.88%4.1K | -624.07%-1.35M | ---958.79K | ---621.93K | ---466.32K | -184.20%-186.71K |
| Other net revenue | -84.90%5.24M | 23.10%64.45M | 235.50%50.34M | 294.63%40.82M | 315.84%34.71M | 48.80%52.35M | -65.03%15.01M | -74.28%10.34M | -66.03%8.35M | -74.40%35.18M |
| Fair value change income | --1M | 483.43%245.21K | ---- | ---- | ---- | 97.74%-63.95K | --264K | --391.8K | ---139.35K | -808.18%-2.83M |
| Invest income | ---- | 364.03%716.9K | 301.59%535.22K | --313.05K | --140.14K | -118.73%-271.52K | -130.08%-265.5K | ---- | ---- | -68.68%1.45M |
| Asset deal income | -100.00%183.12 | 79,945.06%31.53M | 3,371,547.34%31.62M | 3,383,600.82%31.74M | --31.38M | -100.22%-39.49K | -99.99%937.92 | -99.99%937.92 | ---- | -76.65%17.8M |
| Other revenue | 19.37%5.22M | -29.52%36.44M | 33.66%20.74M | -17.31%9.16M | -47.32%4.38M | 140.63%51.7M | -37.88%15.51M | -52.62%11.07M | 24.49%8.31M | -62.03%21.48M |
| Operating profit | 2.11%106.36M | 71.59%355.4M | 68.79%272.1M | 26.40%162.42M | 87.40%104.16M | -52.52%207.12M | -60.30%161.2M | -62.44%128.5M | -68.61%55.58M | -25.61%436.25M |
| Add:Non operating Income | 895.54%5.47M | -2.93%4.23M | -54.44%1.73M | -72.94%639.79K | -73.73%549.23K | -39.85%4.36M | -44.27%3.8M | -57.23%2.36M | 412.41%2.09M | 132.78%7.25M |
| Less:Non operating expense | -24.14%75.96K | 113.46%938.25K | 40.07%570.62K | 180.10%521.71K | 58.08%100.14K | -56.69%439.54K | -57.66%407.39K | -56.31%186.26K | 56.32%63.35K | 396.02%1.01M |
| Total profit | 6.82%111.75M | 69.96%358.69M | 66.02%273.26M | 24.38%162.54M | 81.58%104.61M | -52.30%211.04M | -60.04%164.6M | -62.37%130.67M | -67.54%57.61M | -24.92%442.48M |
| Less:Income tax cost | 16.09%15.24M | 164.68%49.48M | 102.97%31.79M | 51.65%20.42M | 128.25%13.13M | -68.18%18.7M | -73.06%15.66M | -73.18%13.47M | -78.14%5.75M | -22.10%58.76M |
| Net profit | 5.49%96.51M | 60.75%309.21M | 62.13%241.47M | 21.25%142.11M | 76.41%91.48M | -49.87%192.35M | -57.90%148.93M | -60.54%117.21M | -65.69%51.86M | -25.34%383.72M |
| Net profit from continuing operation | 5.49%96.51M | 60.75%309.21M | 62.13%241.47M | 21.25%142.11M | --91.48M | -49.87%192.35M | -57.90%148.93M | -60.54%117.21M | ---- | -25.34%383.72M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --51.86M | ---- |
| Less:Minority Profit | ---1.54K | ---3.81K | ---2.04K | ---170.36 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit of parent company owners | 5.50%96.51M | 60.76%309.21M | 62.13%241.47M | 21.25%142.11M | 76.41%91.48M | -49.87%192.35M | -57.90%148.93M | -60.54%117.21M | -65.69%51.86M | -20.68%383.72M |
| Earning per share | ||||||||||
| Basic earning per share | 5.88%0.18 | 62.86%0.57 | 66.67%0.45 | 23.81%0.26 | 88.89%0.17 | -50.00%0.35 | -58.46%0.27 | -61.82%0.21 | -67.86%0.09 | -21.35%0.7 |
| Diluted earning per share | 20.00%0.18 | 62.50%0.52 | 48.15%0.4 | 9.52%0.23 | 66.67%0.15 | -54.29%0.32 | -58.46%0.27 | -61.82%0.21 | -67.86%0.09 | -21.35%0.7 |
| Other composite income | ||||||||||
| Total composite income | 5.49%96.51M | 60.75%309.21M | 62.13%241.47M | 21.25%142.11M | 76.41%91.48M | -49.87%192.35M | -57.90%148.93M | -60.54%117.21M | -65.69%51.86M | -25.34%383.72M |
| Total composite income of parent company owners | 5.50%96.51M | 60.76%309.21M | 62.13%241.47M | 21.25%142.11M | 76.41%91.48M | -49.87%192.35M | -57.90%148.93M | -60.54%117.21M | -65.69%51.86M | -20.68%383.72M |
| Total composite income of minority owners | ---1.54K | ---3.81K | ---2.04K | ---170.36 | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Beijing Dehao International Accounting Firm (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.